|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
25,230,000 |
Market
Cap: |
99.41(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.99 - $14.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,735 |
21,833 |
25,311 |
129,609 |
Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$349,328 |
Total People Sold |
4 |
4 |
4 |
4 |
Total Sell Transactions |
9 |
20 |
37 |
60 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Singh Monica |
General Counsel |
|
2014-12-23 |
4 |
B |
$8.09 |
$8,089 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
Westphal Christoph H |
Executive Chairman |
|
2014-12-19 |
4 |
B |
$8.50 |
$12,750 |
D/D |
1,500 |
687,016 |
2.81 |
- |
|
Paterson Dan |
Chief Operating Officer |
|
2014-12-19 |
4 |
B |
$8.52 |
$17,040 |
D/D |
2,000 |
45,857 |
2.74 |
- |
|
Forrester Robert |
President and CEO |
|
2014-12-19 |
4 |
B |
$8.66 |
$8,660 |
D/D |
1,000 |
232,114 |
2.81 |
- |
|
Lawton Alison Francis |
Director |
|
2014-11-11 |
4 |
B |
$9.17 |
$22,923 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
Westphal Christoph H |
Executive Chairman |
|
2014-09-30 |
4 |
D |
$8.60 |
$23,753 |
D/D |
(2,762) |
685,516 |
|
- |
|
Kauffman Michael |
Director |
|
2014-09-17 |
4 |
B |
$9.10 |
$27,300 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
Pachter Jonathan |
VP, Head of Research |
|
2014-08-01 |
4 |
D |
$7.39 |
$34,777 |
D/D |
(4,706) |
62,249 |
|
- |
|
Forrester Robert |
President & CEO |
|
2014-08-01 |
4 |
D |
$7.39 |
$60,642 |
D/D |
(8,206) |
231,114 |
|
- |
|
Paterson Dan |
Cheif Business Officer |
|
2014-08-01 |
4 |
D |
$7.39 |
$47,096 |
D/D |
(6,373) |
43,857 |
|
- |
|
Westphal Christoph H |
Executive Chairman |
|
2014-06-30 |
4 |
D |
$9.52 |
$52,646 |
D/D |
(5,530) |
694,734 |
|
- |
|
Barberich Timothy J |
Director |
|
2014-05-30 |
4 |
B |
$9.90 |
$9,895 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
Aldrich Richard |
Director |
|
2014-05-20 |
4 |
B |
$8.37 |
$8,370 |
D/D |
1,000 |
408,142 |
2.39 |
- |
|
Paterson Dan |
Chief Business Officer |
|
2014-05-15 |
4 |
B |
$7.47 |
$7,467 |
D/D |
1,000 |
58,143 |
2.74 |
- |
|
Westphal Christoph H |
Executive Chairman |
|
2014-05-14 |
4 |
B |
$7.56 |
$15,120 |
D/D |
2,000 |
700,264 |
2.81 |
- |
|
Green John B |
Chief Financial Officer |
|
2014-05-13 |
4 |
B |
$7.74 |
$7,740 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
Pachter Jonathan |
VP, Head of Research |
|
2014-05-13 |
4 |
B |
$7.62 |
$7,620 |
D/D |
1,000 |
66,955 |
2.74 |
- |
|
Forrester Robert |
President and CEO |
|
2014-05-13 |
4 |
B |
$7.62 |
$7,620 |
D/D |
1,000 |
239,320 |
2.81 |
- |
|
168 Records found
|
|
Page 7 of 7 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|